Database Query Results : , , ENO1

ENO1, α-Enolase: Click to Expand ⟱
Source:
Type:
Also known as 2-phospho-D-glycerate hydrolase
Is a glycolytic enzyme that catalyzes the conversion of 2-phosphoglyceric acid to phosphoenolpyruvic acid during glycolysis.
ENO1's glycolytic function deregulates cellular energetic, sustains tumor proliferation, and inhibits cancer cell apoptosis. Moreover, ENO1 evades growth suppressors and helps tumors to avoid immune destruction. Besides, ENO1 “moonlights” on the cell surface and acts as a plasminogen receptor, promoting cancer invasion and metastasis by inducing angiogenesis. Overexpression of ENO1 on a myriad of cancer types together with its localization on the tumor surface makes it a great prognostic and diagnostic cancer biomarker as well as an accessible oncotherapeutic target.


Scientific Papers found: Click to Expand⟱
206- Api,    Inhibition of glutamine utilization sensitizes lung cancer cells to apigenin-induced apoptosis resulting from metabolic and oxidative stress
- in-vitro, Lung, H1299 - in-vitro, Lung, H460 - in-vitro, Lung, A549 - in-vitro, CRC, HCT116 - in-vitro, Melanoma, A375 - in-vitro, Lung, H2030 - in-vitro, CRC, SW480
Glycolysis↓, NA?, PGK1↓, ALDOA↓, GLUT1↓, ENO1↓, ATP↓, Casp9↑, Casp3↑, cl‑PARP↑, PI3K/Akt↓, HK1↓, HK2↓,
2291- Ba,  BA,    Baicalein and Baicalin Promote Melanoma Apoptosis and Senescence via Metabolic Inhibition
- in-vitro, Melanoma, SK-MEL-28 - in-vitro, Melanoma, A375
LDHA↓, ENO1↓, PKM2↓, GLUT1↓, GLUT3↓, HK2↓, PFK1↓, GPI↓, TPI↓, GlucoseCon↓, TumCG↓, TumCP↓, mTORC1↓, Hif1a↓, Ki-67↓,
2826- FIS,    Fisetin induces apoptosis in breast cancer MDA-MB-453 cells through degradation of HER2/neu and via the PI3K/Akt pathway
- in-vitro, BC, MDA-MB-453
Apoptosis↑, p‑ENO1↓, DNAdam↑, PI3K↑, p‑Akt↑, HER2/EBBR2↓,
2178- itraC,    Itraconazole inhibits tumor growth via CEBPB-mediated glycolysis in colorectal cancer
- in-vivo, CRC, HCT116
TumCG↓, Glycolysis↓, CEBPB?, ENO1↓, LDHA↓, PKM2↓, GAPDH↓, ECAR↓, OCR↓,

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 4

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned

NA?, 1,  

Redox & Oxidative Stress

HK1↓, 1,  

Mitochondria & Bioenergetics

ATP↓, 1,   OCR↓, 1,  

Core Metabolism/Glycolysis

ALDOA↓, 1,   ECAR↓, 1,   ENO1↓, 3,   p‑ENO1↓, 1,   GAPDH↓, 1,   GlucoseCon↓, 1,   Glycolysis↓, 2,   GPI↓, 1,   HK2↓, 2,   LDHA↓, 2,   PFK1↓, 1,   PGK1↓, 1,   PI3K/Akt↓, 1,   PKM2↓, 2,   TPI↓, 1,  

Cell Death

p‑Akt↑, 1,   Apoptosis↑, 1,   Casp3↑, 1,   Casp9↑, 1,  

Kinase & Signal Transduction

HER2/EBBR2↓, 1,  

DNA Damage & Repair

DNAdam↑, 1,   cl‑PARP↑, 1,  

Proliferation, Differentiation & Cell State

CEBPB?, 1,   mTORC1↓, 1,   PI3K↑, 1,   TumCG↓, 2,  

Migration

Ki-67↓, 1,   TumCP↓, 1,  

Angiogenesis & Vasculature

Hif1a↓, 1,  

Barriers & Transport

GLUT1↓, 2,   GLUT3↓, 1,  

Clinical Biomarkers

HER2/EBBR2↓, 1,   Ki-67↓, 1,  
Total Targets: 37

Pathway results for Effect on Normal Cells:


Total Targets: 0

Scientific Paper Hit Count for: ENO1, α-Enolase
1 Apigenin (mainly Parsley)
1 Baicalein
1 Baicalin
1 Fisetin
1 itraconazole
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:568  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page